المؤلفون: Chiereghin A, Belotti T, Borgatti EC, Fraccascia N, Piccirilli G, Fois M, Borghi M, Turello G, Gabrielli L, Masetti R, Prete A, Fanti S, Lazzarotto T

المصدر: Infection and Drug Resistance, Vol Volume 14, Pp 1185-1190 (2021)

مصطلحات موضوعية: pediatric allogeneic peripheral blood stem cell transplant, gcv-resistant cmv, intolerance to fos, off-label letermovir use., Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://www.dovepress.com/off-label-use-of-letermovir-as-preemptive-anti-cytomegalovirus-therapy-peer-reviewed-article-IDR; https://doaj.org/toc/1178-6973

URL الوصول: https://doaj.org/article/b418ad61670145fc86bb159ac74315ae

المؤلفون: Giulia Piccirilli, Riccardo Masetti, Liliana Gabrielli, Angela Chiereghin, Arcangelo Prete, Tiziana Lazzarotto, Stefano Fanti, Maura Fois, Gabriele Turello, Michele Borghi, Tamara Belotti, Eva Caterina Borgatti, Nicola Fraccascia

المساهمون: Chiereghin A, Belotti T, Borgatti EC, Fraccascia N, Piccirilli G, Fois M, Borghi M, Turello G, Gabrielli L, Masetti R, Prete A, Fanti S, Lazzarotto T.

المصدر: Infection and Drug Resistance, Vol Volume 14, Pp 1185-1190 (2021)
Infection and Drug Resistance

مصطلحات موضوعية: 0301 basic medicine, Foscarnet, 030106 microbiology, Congenital cytomegalovirus infection, gcv-resistant cmv, Case Report, Off-label use, off-label letermovir use, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, chemistry.chemical_compound, Letermovir, 0302 clinical medicine, pediatric allogeneic peripheral blood stem cell transplant, medicine, intolerance to fos, Pharmacology (medical), lcsh:RC109-216, 030212 general & internal medicine, Adverse effect, Pharmacology, business.industry, virus diseases, medicine.disease, Infectious Diseases, chemistry, Viral replication, Immunology, business, Viral load, Cidofovir, medicine.drug

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0d94d177c10651c7901fc2208b2e13d
https://www.dovepress.com/off-label-use-of-letermovir-as-preemptive-anti-cytomegalovirus-therapy-peer-reviewed-article-IDR